 III. To measure Ras mutational status and EGFRHER2 on archival specimens. To determine baseline and post-treatment levels of pERK, pAKT, VEGFR2, CD31, Ki-67MIB-1, and cleaved caspase 3 and to explore the relationship between these correlative endpoints and clinical outcome. 